These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1423 related items for PubMed ID: 18950666
21. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Niu X, Zou W, Liu C, Zhang N, Fu C. Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638 [Abstract] [Full Text] [Related]
22. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W. J Control Release; 2010 Apr 02; 143(1):136-42. PubMed ID: 20056123 [Abstract] [Full Text] [Related]
23. The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells. Jin C, Wu H, Liu J, Bai L, Guo G. J Clin Pharm Ther; 2007 Feb 02; 32(1):41-7. PubMed ID: 17286788 [Abstract] [Full Text] [Related]
24. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK, Mishra P, Mishra AK, Mishra P, Jain S, Agrawal GP. Nanomedicine; 2007 Dec 02; 3(4):246-57. PubMed ID: 18068091 [Abstract] [Full Text] [Related]
25. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations. Zhang Z, Wang X, Li B, Hou Y, Yang J, Yi L. Drug Deliv; 2018 Nov 02; 25(1):166-177. PubMed ID: 29299936 [Abstract] [Full Text] [Related]
26. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X. Biomaterials; 2011 Dec 02; 32(35):9457-69. PubMed ID: 21911250 [Abstract] [Full Text] [Related]
27. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. Zhu Z, Li Y, Li X, Li R, Jia Z, Liu B, Guo W, Wu W, Jiang X. J Control Release; 2010 Mar 19; 142(3):438-46. PubMed ID: 19896997 [Abstract] [Full Text] [Related]
28. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Win KY, Feng SS. Biomaterials; 2006 Apr 19; 27(10):2285-91. PubMed ID: 16313953 [Abstract] [Full Text] [Related]
29. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Zhang Z, Feng SS. Biomaterials; 2006 Jul 19; 27(21):4025-33. PubMed ID: 16564085 [Abstract] [Full Text] [Related]
30. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J, Zhang J, Deng C, Meng F, Zhong Z. Biomacromolecules; 2016 Jul 11; 17(7):2367-74. PubMed ID: 27305935 [Abstract] [Full Text] [Related]
31. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, Jiang X, Yao L, Chen J, Chen H. Biomaterials; 2011 Nov 11; 32(31):8010-20. PubMed ID: 21788069 [Abstract] [Full Text] [Related]
32. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y, Feng SS. Biomaterials; 2005 Oct 11; 26(30):6068-76. PubMed ID: 15894372 [Abstract] [Full Text] [Related]
33. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. Le Broc-Ryckewaert D, Carpentier R, Lipka E, Daher S, Vaccher C, Betbeder D, Furman C. Int J Pharm; 2013 Oct 01; 454(2):712-9. PubMed ID: 23707251 [Abstract] [Full Text] [Related]
34. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Vassileva V, Grant J, De Souza R, Allen C, Piquette-Miller M. Cancer Chemother Pharmacol; 2007 Nov 01; 60(6):907-14. PubMed ID: 17375303 [Abstract] [Full Text] [Related]
35. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery. Shahin M, Lavasanifar A. Int J Pharm; 2010 Apr 15; 389(1-2):213-22. PubMed ID: 20080163 [Abstract] [Full Text] [Related]
36. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Kang BK, Chon SK, Kim SH, Jeong SY, Kim MS, Cho SH, Lee HB, Khang G. Int J Pharm; 2004 Nov 22; 286(1-2):147-56. PubMed ID: 15501011 [Abstract] [Full Text] [Related]
37. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK. Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614 [Abstract] [Full Text] [Related]
38. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M, Zhao Z, Yin L, Tang C, Yin C. Int J Pharm; 2009 May 21; 373(1-2):165-73. PubMed ID: 19429302 [Abstract] [Full Text] [Related]
39. Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on "oxidation therapy". Li X, Lu X, Xu H, Zhu Z, Yin H, Qian X, Li R, Jiang X, Liu B. Mol Pharm; 2012 Feb 06; 9(2):222-9. PubMed ID: 22171565 [Abstract] [Full Text] [Related]
40. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. Fonseca C, Simões S, Gaspar R. J Control Release; 2002 Oct 04; 83(2):273-286. PubMed ID: 12363453 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]